Performance of two low-threshold, population replacement gene drives in cage populations of the yellow fever mosquito, Aedes aegypti.

Publication date: Jun 26, 2025

Aedes aegypti is the predominant vector for arboviruses including dengue, Zika, and chikungunya viruses, which infect over 100 million people annually. Mosquito population replacement in which arbovirus-susceptible mosquitoes in the field are replaced by laboratory-engineered refractory mosquitoes represents a novel genetic control measure to interrupt arboviral disease cycles. For this approach, the engineered mosquitoes need to harbor two genetic components: an antiviral effector construct which is linked to a gene drive (GD). We tested the performance of two single-locus CRISPR/Cas9 based GD for Ae. aegypti population replacement in small cage populations for up to 16 generations. Starting from a low release threshold of 1:9 GD bearing males to wild-type males, we observed two GD constructs in which Cas9 was expressed from two different germline promoters, nanos and zpg, to increase in frequency in all cage populations. By G16, an average of 72% and 82% of individuals from the zpg-GD and nanos-GD populations, respectively harbored at least one GD copy with corresponding increases in allele frequencies. This indicated that the two single-locus, CRISPR/Cas9-based homing GD exhibited continuous super-Mendelian inheritance in populations of Ae. aegypti. Gene drive blocking indel (GDBI, a. k.a. “resistant alleles”) frequency was measured for each discrete generation in pooled samples from the six populations harboring GD. We found that populations with Cas9 expression under control of the nanos-promoter accumulated GDBI at more than twice the rate of those populations harboring the zpg-promoter driven GD. Based on preexisting data sets for homing and GDBI frequencies in addition to the cage trial observations, the relative contributions of sex-specific homing rates, maternal Cas9 deposition and potential fitness effects were modeled in MGDrivE for both GD, further explaining their divergent performance. Our study demonstrates the feasibility of low-threshold, single-locus CRISPR/Cas9 based GD for Ae. aegypti population replacement.

Open Access PDF

Concepts Keywords
Annually Ae
Arboviruses Aegypti
Fitness Based
Genetic Cage
Nanos Cas9
Crispr
Gd
Locus
Low
Mosquitoes
Population
Populations
Replacement
Single
Threshold

Semantics

Type Source Name
disease MESH dengue
pathway REACTOME Release
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease IDO pathogen
disease MESH Allergies
drug DRUGBANK Efavirenz
disease IDO replication
disease MESH infection
disease IDO parasite
pathway REACTOME Homology Directed Repair
disease IDO site
disease IDO assay
drug DRUGBANK Isoxaflutole
drug DRUGBANK Water
disease IDO blood
drug DRUGBANK Ranitidine
disease IDO cell
drug DRUGBANK Albendazole
drug DRUGBANK Aspartame
drug DRUGBANK Corticorelin
disease IDO history
drug DRUGBANK L-Valine
disease MESH yellow fever
disease MESH malaria
pathway KEGG Malaria

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *